Jazz Pharmaceuticals prices $1.1B exchangeable notes offering due 2032
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) has priced a $1.1 billion private offering of 1.875% exchangeable senior notes due 2032, upsized ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
